These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8499426)

  • 1. Single photon emission computerized tomography in obsessive compulsive disorder: a preliminary study.
    Adams BL; Warneke LB; McEwan AJ; Fraser BA
    J Psychiatry Neurosci; 1993 May; 18(3):109-12. PubMed ID: 8499426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression.
    Alptekin K; Degirmenci B; Kivircik B; Durak H; Yemez B; Derebek E; Tunca Z
    Psychiatry Res; 2001 Jul; 107(1):51-6. PubMed ID: 11472864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right basal ganglion hypoperfusion in obsessive compulsive disorder patients demonstrated by Tc-99m-HMPAO brain perfusion spect: a controlled study.
    Topçuoglu V; Cömert B; Karabekiroglu A; Dede F; Erdil TY; Turoglu HT
    Int J Neurosci; 2005 Dec; 115(12):1643-55. PubMed ID: 16287631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
    Stein DJ; Van Heerden B; Wessels CJ; Van Kradenburg J; Warwick J; Wasserman HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1079-99. PubMed ID: 10621951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy and cerebral perfusion in obsessive-compulsive disorder.
    Molina V; Montz R; Martín-Loeches M; Jiménez-Vicioso A; Carreras JL; Rubia FJ
    J Nucl Med; 1995 Dec; 36(12):2234-8. PubMed ID: 8523111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single photon emission computed tomography in obsessive-compulsive disorder.
    Harris GJ; Pearlson GD; Hoehn-Saric R
    Arch Gen Psychiatry; 1993 Jun; 50(6):498-501. PubMed ID: 8498888
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent hyperperfusion in the right orbitofrontal cortex in obsessive-compulsive disorder.
    Matsumoto R; Nakamae T; Yoshida T; Kitabayashi Y; Ushijima Y; Narumoto J; Ito H; Suhara T; Fukui K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1082-4. PubMed ID: 18375030
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions.
    Hugo F; van Heerden B; Zungu-Dirwayi N; Stein DJ
    Depress Anxiety; 1999; 10(3):129-36. PubMed ID: 10604087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of 99mTc-exametazime shown by single photon emission computerized tomography in obsessive-compulsive disorder compared with major depression and normal controls.
    Edmonstone Y; Austin MP; Prentice N; Dougall N; Freeman CP; Ebmeier KP; Goodwin GM
    Acta Psychiatr Scand; 1994 Oct; 90(4):298-303. PubMed ID: 7832002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study.
    Machlin SR; Harris GJ; Pearlson GD; Hoehn-Saric R; Jeffery P; Camargo EE
    Am J Psychiatry; 1991 Sep; 148(9):1240-2. PubMed ID: 1883006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.
    Matsui T; Saxena S; Kawabe J; Matsunaga H; Kohagura K; Higashiyama S; Kiriike N
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):186-9. PubMed ID: 17362437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
    Diler RS; Kibar M; Avci A
    Yonsei Med J; 2004 Feb; 45(1):90-9. PubMed ID: 15004874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroactivation of the Tower of Hanoi in patients with obsessive-compulsive disorder and healthy volunteers].
    Fernández A; Pino Alonso M; Mataix-Cols D; Roca M; Vallejo J; Puchal R; Menchón JM; Martín-Comín J
    Rev Esp Med Nucl; 2003 Nov; 22(6):376-85. PubMed ID: 14588230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography.
    Lucey JV; Costa DC; Busatto G; Pilowsky LS; Marks IM; Ell PJ; Kerwin RW
    Psychiatry Res; 1997 Mar; 74(1):25-33. PubMed ID: 10710160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder among patients with anorexia nervosa and bulimia nervosa.
    Thiel A; Broocks A; Ohlmeier M; Jacoby GE; Schüssler G
    Am J Psychiatry; 1995 Jan; 152(1):72-5. PubMed ID: 7802124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive-compulsive disorder (OCD).
    Lucey JV; Burness CE; Costa DC; Gacinovic S; Pilowsky LS; Ell PJ; Marks IM; Kerwin RW
    Br J Med Psychol; 1997 Dec; 70 ( Pt 4)():403-11. PubMed ID: 9429759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients.
    Hoehn-Saric R; Pearlson GD; Harris GJ; Machlin SR; Camargo EE
    Am J Psychiatry; 1991 Sep; 148(9):1243-5. PubMed ID: 1883007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single photon emission computed tomography (SPECT) in obsessive-compulsive disorder before and after treatment with inositol.
    Carey PD; Warwick J; Harvey BH; Stein DJ; Seedat S
    Metab Brain Dis; 2004 Jun; 19(1-2):125-34. PubMed ID: 15214512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder.
    Hasselbalch SG; Hansen ES; Jakobsen TB; Pinborg LH; Lønborg JH; Bolwig TG
    Acta Psychiatr Scand; 2007 May; 115(5):388-94. PubMed ID: 17430417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Yale-Brown Scale: instrument for assessing the severity of obsessive-compulsive disorders].
    Kiejna A; Grzesiak M; Małyszczak K
    Psychiatr Pol; 1998; 32(1):69-76. PubMed ID: 9594585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.